Agilent annotation source
1
0
Entering edit mode
Axel Klenk ★ 1.0k
@axel-klenk-3224
Last seen 13 hours ago
UPF, Barcelona, Spain
Dear BioC list and Biocore Data Team, we are using various Agilent arrays and the recent paper by Gertz et al. ( http://www.biomedcentral.com/1471-2164/10/566 ) made me feel a little bit uneasy about the annotation provided by that vendor. As far as I understand, BioC annotation, e.g. in package hgug4112a.db, is using EntrezGene IDs as keys to retrieve public annotation for a given EntrezGene entry -- but where does the mapping from Agilent's Oligo ID to EntrezGene come from? I have tried to find the answer in the package's reference manual and help pages but would prefer to be absolutely sure in this case... Thanks in advance, - axel P.S., I do not yet have much experience with sequence analysis in BioC and would also be grateful for pointers to packages that could help me verify oligo mappings myself. Axel Klenk Research Informatician Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH-4123 Allschwil / Switzerland The information of this email and in any file transmitted with it is strictly confidential and may be legally privileged. It is intended solely for the addressee. If you are not the intended recipient, any copying, distribution or any other use of this email is prohibited and may be unlawful. In such case, you should please notify the sender immediately and destroy this email. The content of this email is not legally binding unless confirmed by letter. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them to be the views of the sender's company. For further information about Actelion please see our website at http://www.actelion.com
Annotation hgug4112a oligo Annotation hgug4112a oligo • 944 views
ADD COMMENT
0
Entering edit mode
@james-w-macdonald-5106
Last seen 19 hours ago
United States
Hi Axel, axel.klenk at actelion.com wrote: > Dear BioC list and Biocore Data Team, > > we are using various Agilent arrays and the recent paper by Gertz et al. > ( http://www.biomedcentral.com/1471-2164/10/566 ) made me feel a > little bit uneasy about the annotation provided by that vendor. > > As far as I understand, BioC annotation, e.g. in package hgug4112a.db, > is using EntrezGene IDs as keys to retrieve public annotation for a given > EntrezGene entry -- but where does the mapping from Agilent's Oligo ID > to EntrezGene come from? The first mapping is usually vendor --> Entrez Gene using the manufacturer's annotation data. However, in this case, it appears that the mapping was vendor --> GenBank and then all other mappings were from GenBank. From ?hgug4112aACCNUM: For chip packages such as this, the ACCNUM mapping comes directly from the manufacturer. This is different from other mappings which are mapped onto the probes via an Entrez Gene identifier. > > I have tried to find the answer in the package's reference manual and help > pages but would prefer to be absolutely sure in this case... > > Thanks in advance, > > - axel > > > P.S., I do not yet have much experience with sequence analysis in BioC > and would also be grateful for pointers to packages that could help me > verify oligo mappings myself. There may be more recent examples of how to do this, but the GenomeSearching vignette: http://bioconductor.org/packages/2.5/bioc/vignettes/BSgenome/inst/doc/ GenomeSearching.pdf has a good example in section 8. You can then use the output from that alignment with e.g. rtracklayer to visualize, or the org.Xx.eg.db package to map to genes. Best, Jim > > > Axel Klenk > Research Informatician > Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH-4123 Allschwil / > Switzerland > > > > > The information of this email and in any file transmitted with it is strictly confidential and may be legally privileged. > It is intended solely for the addressee. If you are not the intended recipient, any copying, distribution or any other use of this email is prohibited and may be unlawful. In such case, you should please notify the sender immediately and destroy this email. > The content of this email is not legally binding unless confirmed by letter. > Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them to be the views of the sender's company. For further information about Actelion please see our website at http://www.actelion.com > > _______________________________________________ > Bioconductor mailing list > Bioconductor at stat.math.ethz.ch > https://stat.ethz.ch/mailman/listinfo/bioconductor > Search the archives: http://news.gmane.org/gmane.science.biology.informatics.conductor -- James W. MacDonald, M.S. Biostatistician Douglas Lab University of Michigan Department of Human Genetics 5912 Buhl 1241 E. Catherine St. Ann Arbor MI 48109-5618 734-615-7826 ********************************************************** Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues
ADD COMMENT
0
Entering edit mode
On Thu, Feb 4, 2010 at 9:29 AM, James W. MacDonald <jmacdon at="" med.umich.edu=""> wrote: > Hi Axel, > > axel.klenk at actelion.com wrote: >> >> Dear BioC list and Biocore Data Team, >> >> we are using various Agilent arrays and the recent paper by Gertz et al. >> ( http://www.biomedcentral.com/1471-2164/10/566 ) made me feel a >> little bit uneasy about the annotation provided by that vendor. >> >> As far as I understand, BioC annotation, e.g. in package hgug4112a.db, >> is using EntrezGene IDs as keys to retrieve public annotation for a given >> EntrezGene entry -- but where does the mapping from Agilent's Oligo ID >> to EntrezGene come from? > > The first mapping is usually vendor --> Entrez Gene using the manufacturer's > annotation data. However, in this case, it appears that the mapping was > vendor --> GenBank and then all other mappings were from GenBank. From > ?hgug4112aACCNUM: > > For chip packages such as this, the ACCNUM mapping comes directly from the > manufacturer. This > is different from other mappings which are mapped onto the probes via an > Entrez Gene identifier. > >> >> I have tried to find the answer in the package's reference manual and help >> pages but would prefer to be absolutely sure in this case... >> >> Thanks in advance, >> ?- axel >> >> >> P.S., I do not yet have much experience with sequence analysis in BioC >> and would also be grateful for pointers to packages that could help me >> verify oligo mappings myself. > > There may be more recent examples of how to do this, but the GenomeSearching > vignette: > > http://bioconductor.org/packages/2.5/bioc/vignettes/BSgenome/inst/do c/GenomeSearching.pdf > > has a good example in section 8. You can then use the output from that > alignment with e.g. rtracklayer to visualize, or the org.Xx.eg.db package to > map to genes. I'll just add a bit to Jim's suggestions. For the 50-60mers on the Agilent array, one probably wants to map to a transcript database and NOT the genome, as many of these probes will cross exon boundaries. A program like blat or gmap (or bioconductor tools) can align the agilent probes to a trancript database such as RefSeq or Ensembl known transcripts. In the end, alignment to transcripts is what is typically sought, anyway, for gene expression arrays. Sean >> >> >> Axel Klenk >> Research Informatician >> Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH-4123 Allschwil / >> Switzerland >> >> >> >> >> The information of this email and in any file transmitted with it is >> strictly confidential and may be legally privileged. >> It is intended solely for the addressee. If you are not the intended >> recipient, any copying, distribution or any other use of this email is >> prohibited and may be unlawful. In such case, you should please notify the >> sender immediately and destroy this email. >> The content of this email is not legally binding unless confirmed by >> letter. >> Any views expressed in this message are those of the individual sender, >> except where the message states otherwise and the sender is authorised to >> state them to be the views of the sender's company. For further information >> about Actelion please see our website at http://www.actelion.com >> >> _______________________________________________ >> Bioconductor mailing list >> Bioconductor at stat.math.ethz.ch >> https://stat.ethz.ch/mailman/listinfo/bioconductor >> Search the archives: >> http://news.gmane.org/gmane.science.biology.informatics.conductor > > -- > James W. MacDonald, M.S. > Biostatistician > Douglas Lab > University of Michigan > Department of Human Genetics > 5912 Buhl > 1241 E. Catherine St. > Ann Arbor MI 48109-5618 > 734-615-7826 > ********************************************************** > Electronic Mail is not secure, may not be read every day, and should not be > used for urgent or sensitive issues > _______________________________________________ > Bioconductor mailing list > Bioconductor at stat.math.ethz.ch > https://stat.ethz.ch/mailman/listinfo/bioconductor > Search the archives: > http://news.gmane.org/gmane.science.biology.informatics.conductor >
ADD REPLY

Login before adding your answer.

Traffic: 485 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6